Andrea Orthmann
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
Journal: Journal of neuro-oncology
Published: July 18, 2023
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Journal: Frontiers in oncology
Published: December 22, 2022
M01 as a novel drug enhancer for specifically targeting the blood-brain barrier.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 21, 2020
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies.
Journal: Journal of translational medicine
Published: November 22, 2016
Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin Liposomes.
Journal: Journal of biomedical nanotechnology
Published: June 16, 2016
How perifosine affects liposome-encapsulated drug delivery across a cell barrier.
Journal: Therapeutic delivery
Published: May 22, 2015
Treatment of experimental brain metastasis with MTO-liposomes: impact of fluidity and LRP-targeting on the therapeutic result.
Journal: Pharmaceutical research
Published: January 05, 2012
Improving the transport of chemotherapeutic drugs across the blood-brain barrier.
Journal: Expert review of clinical pharmacology
Published: November 26, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026